Mrs Winifred Gail Koehler, WHCNP | |
5955 Zeamer Ave, Elmendorf Afb, AK 99506-3702 | |
(907) 580-1360 | |
Not Available |
Full Name | Mrs Winifred Gail Koehler |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 20 Years |
Location | 5955 Zeamer Ave, Elmendorf Afb, Alaska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629069398 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LW0102X | Nurse Practitioner - Women's Health | AP2060 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Womens Care Of Alaska Pc | 8921091091 | 9 |
News Archive
PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today reported its financial results for the first quarter of 2012.
A new poll finds 55 percent of state residents back the federal health law, even as Maryland plans to spend $2 million to address a problem with the online insurance marketplace. In related news, the deadline is approaching for states to spend federal grants they received to set up exchanges.
A Dutch study has revealed that as many as 13% of healthy adults may have some type of undiagnosed abnormality in the brain.
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced final data from a randomized, controlled Phase 2 trial of picoplatin in metastatic colorectal cancer (CRC) patients.
› Verified 4 days ago
Entity Name | Womens Care Of Alaska Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174702468 PECOS PAC ID: 8921091091 Enrollment ID: O20040405001520 |
News Archive
PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today reported its financial results for the first quarter of 2012.
A new poll finds 55 percent of state residents back the federal health law, even as Maryland plans to spend $2 million to address a problem with the online insurance marketplace. In related news, the deadline is approaching for states to spend federal grants they received to set up exchanges.
A Dutch study has revealed that as many as 13% of healthy adults may have some type of undiagnosed abnormality in the brain.
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced final data from a randomized, controlled Phase 2 trial of picoplatin in metastatic colorectal cancer (CRC) patients.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Winifred Gail Koehler, WHCNP 5955 Zeamer Ave, Elmendorf Afb, AK 99506-3702 Ph: (907) 580-1360 | Mrs Winifred Gail Koehler, WHCNP 5955 Zeamer Ave, Elmendorf Afb, AK 99506-3702 Ph: (907) 580-1360 |
News Archive
PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today reported its financial results for the first quarter of 2012.
A new poll finds 55 percent of state residents back the federal health law, even as Maryland plans to spend $2 million to address a problem with the online insurance marketplace. In related news, the deadline is approaching for states to spend federal grants they received to set up exchanges.
A Dutch study has revealed that as many as 13% of healthy adults may have some type of undiagnosed abnormality in the brain.
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced final data from a randomized, controlled Phase 2 trial of picoplatin in metastatic colorectal cancer (CRC) patients.
› Verified 4 days ago
Pamela Karen Stafford, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Zeamer Street, Elmendorf Afb, AK 99506 Phone: 907-580-2962 | |
Elizabeth P. Kuss, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Elmendorf Afb, AK 99506 Phone: 907-580-0282 | |
Jill G Mandt, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5955 Zeamer Ave, Elmendorf Afb, AK 99506 Phone: 907-580-2371 | |
Mrs. Betsy Lynne Demay, WHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5955 Zeamer Ave, Elmendorf Afb, AK 99506 Phone: 907-580-2935 |